Human blood dendritic cell subsets exhibit discriminative pattern recognition receptor profiles

Immunology

Volumn 142, Issue 2, 2014, Pages 279-288

  Lundberg, Kristina ^a   Rydnert, Frida ^a   Greiff, Lennart ^b   Lindstedt, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C type lectin receptors; Human dendritic cell subsets; Pattern recognition receptors; Toll like receptors

Indexed keywords

CD123 ANTIGEN; CD16 ANTIGEN; CD1C ANTIGEN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR;

ADULT; ALLERGIC RHINITIS; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CELL POPULATION; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RANDOM FOREST;

C-TYPE LECTIN RECEPTORS; HUMAN DENDRITIC CELL SUBSETS; PATTERN RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS;

ADULT; ANTIGENS, CD; DENDRITIC CELLS; FEMALE; HUMANS; HYPERSENSITIVITY; LECTINS, C-TYPE; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; RHINITIS, ALLERGIC, PERENNIAL; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84899109357     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12252     Document Type: Article

References (54)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
2. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-50.
3. Osorio F, Reis e Sousa C. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 2011; 34:651-64.
4. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 2009; 9:465-79.
5. Engering AJ, Cella M, Fluitsma DM, Hoefsmit EC, Lanzavecchia A, Pieters J. Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 1997; 417:183-7.
6. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000; 151:673-84.
7. Bonifaz LC, Bonnyay DP, Charalambous A et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004; 199:815-24.
8. He LZ, Crocker A, Lee J et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol 2007; 178:6259-67.
9. + T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Eur J Immunol 2010; 40:1255-65.
10. Birkholz K, Schwenkert M, Kellner C et al. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 2010; 116:2277-85.
11. + T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010; 116:1685-97.
12. + T cells. J Exp Med 2012; 209:109-21.
13. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, de Vries IJ, Adema GJ. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 2008; 111:4245-53.
14. + myeloid dendritic cells. Blood 2012; 119:2284-92.
15. Tacken PJ, de Vries IJ, Gijzen K et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-CD209/DC-SIGN antibody. Blood 2005; 106:1278-85.
16. Tacken PJ, Figdor CG. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines. Semin Immunol 2011; 23:12-20.
17. ClinicalTrials.gov_Identifier:NCT01127464. DCVax Plus Poly ICLC in Healthy Volunteers.
18. ClinicalTrials.gov_IdentifierNCT01522820. Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors.
19. ClinicalTrials.gov_Identifier:NCT00648102. Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (CDX1307-02).
20. Flynn BJ, Kastenmuller K, Wille-Reece U et al. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci USA 2011; 108:7131-6.
21. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002; 100:4512-20.
22. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284:1835-7.
23. Hadeiba H, Lahl K, Edalati A et al. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 2012; 36:438-50.
24. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207:1247-60.
25. Piccioli D, Tavarini S, Borgogni E et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007; 109:5371-9.
26. Mittag D, Proietto AI, Loudovaris T, Mannering SI, Vremec D, Shortman K, Wu L, Harrison LC. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol 2011; 186:6207-17.
27. Lindstedt M, Lundberg K, Borrebaeck CA. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J Immunol 2005; 175:4839-46.
28. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol BioSyst 2009; 5:1512-26.
29. high) dendritic cells in human nasal allergy. J Immunol 2000; 165:4062-8.
30. Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001; 56:823-6.
31. Kayserova J, Zentsova-Jaresova I, Budinsky V et al. Selective increase in blood dendritic cell antigen-3-positive dendritic cells in bronchoalveolar lavage fluid in allergic patients. Scand J Immunol 2012; 75:305-13.
32. Lundberg K, Greiff L, Borrebaeck CA, Lindstedt M. FcεRI levels and frequencies of peripheral blood dendritic cell populations in allergic rhinitis. Hum Immunol 2010; 71:931-3.
33. Barrett NA, Maekawa A, Rahman OM, Austen KF, Kanaoka Y. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J Immunol 2009; 182:1119-28.
34. Deslee G, Charbonnier AS, Hammad H et al. Involvement of the mannose receptor in the uptake of Der p 1, a major mite allergen, by human dendritic cells. J Allergy Clin Immunol 2002; 110:763-70.
35. Hsu SC, Chen CH, Tsai SH et al. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells. J Biol Chem 2010; 285:7903-10.
36. Huang HJ, Lin YL, Liu CF, Kao HF, Wang JY. Mite allergen decreases DC-SIGN expression and modulates human dendritic cell differentiation and function in allergic asthma. Mucosal Immunol 2011; 4:519-27.
37. Royer PJ, Emara M, Yang C et al. The mannose receptor mediates the uptake of diverse native allergens by dendritic cells and determines allergen-induced T cell polarization through modulation of IDO activity. J Immunol 2010; 185:1522-31.
38. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-6.
39. Barrett NA, Rahman OM, Fernandez JM et al. Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes. J Exp Med 2011; 208:593-604.
40. Li DQ, Zhang L, Pflugfelder SC et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol 2011; 128:1318-25 e2.
41. Herzenberg LA, Tung J, Moore WA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 2006; 7:681-5.
42. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 2006; 69:1037-42.
43. Cortes C, Vapnik V. Support-vector networks. Mach Learn 1995; 20:273-97.
44. Arlot S, Celisse A. A survey of cross-validation procedures for model selection. Stat Surv 2010; 4:40-79.
45. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 2000; 97:10101-6.
46. Genser B, Cooper PJ, Yazdanbakhsh M, Barreto ML, Rodrigues LC. A guide to modern statistical analysis of immunological data. BMC Immunol 2007; 8:27.
47. Breiman L. Random forests. Mach Learn 2001; 45:5-32.
48. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol 2006; 35:387-93.
49. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
50. Nozohoor S, Sjogren J, Ivert T, Hoglund P, Nilsson J. Validation of a modified EuroSCORE risk stratification model for cardiac surgery: the Swedish experience. Eur J Cardiothorac Surg 2011; 40:185-91.
51. Tel J, Benitez-Ribas D, Hoosemans S et al. DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur J Immunol 2011; 41:1014-23.
52. Chieppa M, Bianchi G, Doni A et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 2003; 171:4552-60.
53. + regulatory T cells. J Immunol 2004; 173:4433-42.
54. Shreffler WG, Castro RR, Kucuk ZY et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol 2006; 177:3677-85.